Previous Article | Next Article ![]()
Infect. Immun., 01 1998, 145-150, Vol 66, No. 1
N Vazquez, TJ Walsh, D Friedman, SJ Chanock and CA Lyman
Interleukin-15 (IL-15) is a newly described cytokine that shares biological
activities with IL-2. We report here results demonstrating the ability of
IL-15 to enhance superoxide production and antifungal activity of human
monocytes. After 18 and 48 h of treatment with IL-15, human elutriated
monocytes manifested enhanced superoxide production in response to either
phorbol myristate acetate or opsonized Candida albicans blastoconidia.
Similar results were obtained when monocytes were treated with IL-2, but to
a lesser extent. Combination studies with IL-15 and IL-2 showed no additive
or synergistic effects. Following incubation of monocytes with IL-15 for 18
h, there was no significant increase in mRNA transcripts for components of
the NADPH oxidase complex, p40-phox, p47-phox, and gp91-phox, suggesting a
posttranscriptional modulation of enhanced superoxide production.
Antibodies against the gamma chain of the IL-2 receptor and, to a lesser
extent, against the beta chain partially abrogated the IL-15- mediated
enhanced superoxide production. Additionally, human monocytes showed
enhanced killing activity against C. albicans after 18 h of incubation with
IL-15 or IL-2, but this treatment did not enhance the ability of these
cells to phagocytose the organism. In addition, the enhanced fungicidal
activity seen after 18 h of treatment was no longer detectable after 48 h
of cytokine treatment. Culture supernatants from the IL-15-treated
monocytes were assayed for the presence of other proinflammatory cytokines.
IL-15 treatment did not induce the release of detectable levels of tumor
necrosis factor alpha, IL-1beta, or IL- 12. Our results indicate that IL-15
upregulates the microbicidal activity of human monocytes against C.
albicans.
Copyright © 1998, American Society for Microbiology
Interleukin-15 augments superoxide production and microbicidal activity of human monocytes against Candida albicans
Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|